If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAthelney Tst. Regulatory News (ATY)

Share Price Information for Athelney Tst. (ATY)

Share Price is delayed by 15 minutes
Get Live Data
165.00    0.00 (0.00%)
Bid:
140.00
Ask:
190.00
Spread: 50.00 (35.714%)
Market Cap: £3.56m
ATY Live PriceLast checked at - London Stock Exchange

Intraday Athelney Tst. Share Chart

Net Asset Value(s)

2 Jul 2026 12:35

RNS Number : 8258K
Athelney Trust PLC
02 July 2026
 

 

Athelney Trust PLC

 

Legal Entity Identifier:

213800ON67TJC7F4DL05

The unaudited net asset value of Athelney Trust was 163.1p at 30 June 2026.

Fund Manager's comment for June 2026

The US economy remained resilient in June, supported by stronger-than-expected manufacturing activity and modest improvement in services. The Federal Reserve left interest rates unchanged, maintaining a cautious stance amid elevated inflation.

The Eurozone economy contracted in the first quarter, reflecting weaker consumer demand, lower investment and trade, although much of the decline was driven by Ireland. Manufacturing remained in modest expansion while services showed signs of stabilising. Inflation pressures eased slightly, but business confidence and employment remained subdued despite improving geopolitical conditions.

The UK economy expanded by 0.6% in the first quarter of 2026, its strongest quarterly growth in a year, driven primarily by a rebound in the services sector. Manufacturing and construction also contributed modestly to growth, while annual GDP increased 0.9%. The data suggests the UK economy continues to demonstrate resilience despite ongoing inflationary pressures and a challenging global economic environment.

The MSCI World Index declined by 0.8% in June, driven for the most part by a decline in the large technology stocks in the US with the Nasdaq down by 2.81% and the S&P500 down by 1.06%. In the UK, the FTSE 100 rose a modest 0.84%, supported by its large-cap mining constituents, while the more domestically focused FTSE 250 fell by 1.76% with the SmallCap Index down by 0.03%. The AIM Index significantly underperformed, declining by 5.98% as investor sentiment towards smaller UK growth companies remained subdued.

Our portfolio increased by 1.72% and the NAV was up by 1.37% for the month after providing for all fees and expenses. During the month, we trimmed our holdings in Cake Box and RELX, and added to our holdings in Liontrust Asset Management, Spectra Systems and S&U.

Turning to the results for our portfolio companies, Cake Box delivered a strong FY2026, with revenue and earnings growing over 40%, supported by new store openings and the successful integration of Ambala. Fever-Tree reported a solid start to the year, reaffirmed full-year guidance and announced a further £30 million share buyback. The company continues to invest heavily in its US expansion. Raspberry Pi upgraded FY2026 guidance after strong first-half demand and profitability exceeded expectations. Growth was driven by higher sales volumes, an improved product mix and favourable component costs.

PayPoint delivered record underlying profits and earnings, completed the acquisition of AperiData to strengthen its payments platform, and continues to invest for long-term growth while maintaining its share buyback programme. Liontrust reported a weaker year as fund outflows weighed on earnings, although assets under management improved towards year-end. The acquisition of River Global is expected to broaden the firm's investment capabilities and distribution.

Wise continued to deliver strong growth, with active customers, payment volumes and profitability all increasing significantly. Active Customers Rose 21%, cross-border volumes increased 31% to $243.5 billion and net revenue was up 19% to $2.503 billion The company announced a further share buyback and expects another year of double-digit revenue growth.

The largest contributors to performance during the month were Games Workshop, Spectra Systems and Mony Group while Yu Group, BTG and AEW UK Reit were the largest detractors from performance.

Fact Sheet

An accompanying fact sheet which includes the information above as well as wider details on the portfolio can be found on the Fund's website www.athelneytrust.co.uk under "About" then select "Latest Monthly Fact Sheet".

Background Information

Dr. Emmanuel (Manny) Pohl AM

Manny is Chairman and Chief Investment Officer of E C Pohl & Co ("ECP"), an investment management company and has been a major shareholder in Athelney trust for many years.

E C Pohl & co is licensed by the Australian Financial services (license no.421704).

www.ecpohl.com

www.ecpam.com

Manny Pohl and the ECP group has AUD2.7bn (£1.5 billion) under its management including four listed investment companies, three listed in Australia and one in the UK:

· Flagship Investments (ASX code:FSI)

 https://flagshipinvestments.com.au

· ECP Emerging Growth (ASX code: ECP)

 https://ecpam.com/emerging

· Global Masters Fund Limited (ASX code: GFL)

 www.globalmastersfund.com.au

· Athelney Trust plc (LSE code: ATY)

 www.athelneytrust.co.uk

Athelney Trust plc Investment Policy

 The investment objective of the Trust is to provide shareholders with prospects of long-term capital growth with the risks inherent in small cap investment minimised through a spread of holdings in quality small cap companies that operate in various industries and sectors. The Fund Manager also considers that it is important to maintain a progressive dividend record.

The assets of the Trust are allocated predominantly to companies with either a full listing on the London Stock Exchange or a trading facility on AIM or ISDX. The assets of the Trust have been allocated in two main ways: first, to the shares of those companies which have grown steadily over the years in terms of profits and dividends but, despite this progress, the market rating is favourable when compared to future earnings and dividends; second, to those companies whose shares are standing at a favourable level compared with the value of land, buildings or cash in the balance sheet.

Athelney Trust was founded in 1994. In 1996 it was one of the ten pioneer members of the Alternative Investment Market ("AIM"). In 2008 the shares became fully listed on the main market of the London Stock Exchange. Athelney Trust has a successful progressive dividend growth record and the dividend has grown every year since 2004. According to the Association of Investment Companies (AIC) Athelney Trust is a "Dividend Hero" being one of only a few investment companies that have increased their dividend every year for 20 years or more. See link

https://www.theaic.co.uk/income-finder/dividend-heroes

Website

www.athelneytrust.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVBBGDRUXGDGLD
Date   Source Headline
25th Jul 202311:37 amRNSHalf-year Report
4th Jul 20238:50 amRNSNet Asset Value(s)
5th Jun 20237:28 amRNSNet Asset Value(s)
3rd May 202310:14 amRNSNet Asset Value(s)
4th Apr 202312:05 pmRNSNet Asset Value(s)
17th Mar 20231:15 pmRNSResult of AGM
2nd Mar 202312:39 pmRNSNet Asset Value(s)
13th Feb 20236:02 pmRNSAnnual Financial Report
2nd Feb 20237:00 amRNSNet Asset Value(s)
9th Jan 202310:11 amRNSNet Asset Value(s)
5th Dec 20227:51 amRNSNet Asset Value(s)
2nd Nov 20227:50 amRNSNet Asset Value(s)
4th Oct 20229:02 amRNSNet Asset Value(s)
5th Sep 20227:09 amRNSNet Asset Value(s)
2nd Aug 202211:57 amRNSNet Asset Value(s)
26th Jul 202212:44 pmRNSHalf-year Report
4th Jul 20229:13 amRNSNet Asset Value(s)
6th Jun 20229:36 amRNSNet Asset Value(s)
4th May 20227:56 amRNSNet Asset Value(s)
5th Apr 20223:10 pmRNSAGM Statement
4th Apr 20229:55 amRNSNet Asset Value(s)
2nd Mar 202211:33 amRNSNet Asset Value(s)
23rd Feb 20221:13 pmRNSAnnual Financial Report
2nd Feb 20229:05 amRNSNet Asset Value(s)
12th Jan 20225:03 pmRNSHolding(s) in Company
12th Jan 20225:00 pmRNSHolding(s) in Company
12th Jan 20225:00 pmRNSHolding(s) in Company
5th Jan 20228:14 amRNSNet Asset Value(s)
3rd Dec 202112:00 pmRNSNet Asset Value(s)
2nd Nov 20218:12 amRNSNet Asset Value(s)
4th Oct 202111:40 amRNSNet Asset Value(s)
2nd Sep 202111:44 amRNSNet Asset Value(s)
3rd Aug 20211:18 pmRNSNet Asset Value(s)
27th Jul 202111:20 amRNSHalf-year Report
2nd Jul 20218:32 amRNSNet Asset Value(s)
3rd Jun 20218:19 amRNSNet Asset Value(s)
5th May 20219:19 amRNSNet Asset Value(s)
15th Apr 20219:48 amRNSMajor shareholding notification
15th Apr 20219:46 amRNSMajor shareholder notification
6th Apr 202110:01 amRNSNet Asset Value(s)
30th Mar 20211:20 pmRNSResult of AGM
2nd Mar 202110:11 amRNSNet Asset Value(s)
24th Feb 202112:54 pmRNSAnnual Financial Report
2nd Feb 20219:55 amRNSNet Asset Value(s)
5th Jan 202112:01 pmRNSNet Asset Value(s)
2nd Dec 202012:22 pmRNSNet Asset Value(s)
3rd Nov 20209:30 amRNSNet Asset Value(s)
12th Oct 20209:43 amRNSDirector Declaration
2nd Oct 202011:05 amRNSNet Asset Value(s)
3rd Sep 202010:49 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.